GENEVA, July 6 -- FRED HUTCHINSON CANCER CENTER filed a patent application (US2025/061239) for “DNA METHYLATION BIOMARKERS FOR DETECTION OF ESOPHAGEAL ADENOCARCINOMA AND HIGH-GRADE DYSPLASIA”. With publication no. WO/2026/143173, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12Q 1/6886
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....